Richard Schwartz & Associates
Will Take Care of You & Your Claim
Users of the Weight Loss Drug Lorcaserin May Be Eligible for Compensation After a Cancer Diagnosis
Drugs sold to help with weight loss have caused their share of health issues among patients over the years. Belviq and Belviq XR, sold by Eisai Co., can now be added to the list of medications that may cause more harm than help. These medications were aimed at individuals considered “overweight” or “obese” and meant to aid weight loss efforts that also included diet and exercise. Recently, a longitudinal study by the FDA found unexpected side effects related to the drug, which has the active ingredient lorcaserin.
Over 5 years, a randomized, double-blind, placebo-controlled clinical trial of Belviq found an increased risk of several cancers among users of the drug as compared to those on a placebo. These unexpected findings led the FDA to recall the product in February of 2020. However, in the 8 years Belviq and Belviq XR were on the market, they likely reached over a million Americans, any of whom could have been affected. If you or a loved one received a cancer diagnosis after using Belviq or Belviq XR, our team can help you determine whether you may be eligible for compensation.
Considering the Impact of Belviq
Because the Belviq study was commissioned to determine whether the drug was linked to cardiovascular injury (a danger caused by multiple other weight loss drugs), the medication’s links to cancer took everyone by surprise. Therefore, researchers do not know what components of the drug may be related to the development of this disease.
However, they did find the cancer-causing agent in Belviq does not confine risk to one system. Many variants of cancer occurred at higher rates among study patients, including those that affect the:
- Colorectal system
Belviq users should note the above are not the only cancers that might be linked to the medication. If you were prescribed Belviq when you started dieting and exercising and later received a cancer diagnosis of any sort, come talk to our team. We can help you determine whether filing a lawsuit against Eisai could result in compensation.
What to Do If You Take Belviq
Belviq and Belviq XR have been steady sellers in the U.S. market; in 2014, Eisai made nearly $50 million in sales. If you are one of its many, many users, here’s what you need to know.
First, the FDA recommends all patients stop taking Belviq, Belviq XR, and any other drugs that contain lorcaserin and dispose of them in a safe manner. Your doctor can discuss other weight-loss medications and/or programs you can try.
Second, if you have received a cancer diagnosis since beginning Belviq, gather all the information you have about your diagnosis and treatment. This evidence could help prove your case. The same goes for any records of your Belviq prescriptions and/or use.
If you used the drug and have not been diagnosed with cancer, we advise you to ask your doctor for information on warning signs and conserve records of your prescription. Though the increase in risk appears to be modest, if you do develop cancer due to Belviq, we want to make sure you have the evidence you need to file a claim.
Call Our Mississippi Attorneys to Start Your Claim
In the 8 years it’s been available to U.S. consumers, Belviq has lined the pockets of pharmaceutical execs. Companies that make hundreds of millions off dangerous medications like this one should not be allowed to keep that money after removing a drug from the market. Not only do most cancer patients need costly treatment, but a diagnosis can disrupt their life as well as the lives of their loved ones. Anyone facing this situation due to a pharmaceutical company’s failure to identify risks associated with their drugs deserves the chance to get justice. Reach out to the dangerous drug attorneys at Richard Schwartz & Associates today to see if you could be eligible for compensation.